comprehensive -WSS

comprehensive

author：focus 2025-08-25 05:57:05 - browse：29

Jacob S. Van Naarden (left), Athena Countouriotis( center), and Vlad Coric (right) on stage at the 2023 STAT Summit. — From left, Eli Lilly's Jacob S. Van Naarden, Avenzo's Athena Countouriotis, and Biohaven's Vlad Coric on stage at the 2023 STAT Summit. STAT

What does it feel like to run a biotech startup and then get “the call” — the one from the big pharma CEO who wants to acquire your company for billions of dollars?

At the 2023 STAT Summit on Wednesday, senior biotech writer Adam Feuerstein posed this question to three people very qualified to answer it: Vlad Coric, chairman and CEO of Biohaven, which was acquired by Pfizer in 2022 for $11.6 billion; Jacob Van Naarden, former COO of Loxo Oncology, which was acquired by Eli Lilly (where Van Naarden is now executive vice president) for $8 billion in 2019; and Athena Countouriotis, whose company Turning Point Therapeutics was acquired by BMS for $4 billion in 2022.

“Imagine you’re going through your typical day, and you get a message: Albert Bourla, chairman and CEO of Pfizer, wants to talk at six o’clock tonight,” said Coric, whose company had a successful migraine drug on the market and had just completed an IPO at the time.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Advocates call out 'SNL' over stereotypes, errors in sickle cell skit

hotspot

focus

WSS

David Ricks of Eli Lilly: best biopharma CEO of 2023

How to keep neuroscience’s past racism from being its future

Petition to FDA: Get the lead out of consumer hair dyes

Insurance companies sue energy corporation after it was blamed for helping start Colorado wildfire

HCA sued by state AG for quality issues at Mission Health

Elizabeth Holmes on track for early release from her 11

focus

comprehensive

knowledge

Peter Hotez and the public health issue of online harassment

Why health records don't always know when patients are dead

Wildfire smoke exposes gaps in outdoor worker protections

Humana’s Medicare Advantage lawsuit should be tossed, DOJ says

Moonlake's readout produced a cash windfall. Risks remain

Living with Fabry disease, a condition that causes chronic pain

The cancer drug shortage isn’t new — and neither are the solutions

In Spain, a hospital brews its own CAR

Tori Bowie and the unacceptable rates of Black maternal death

Three trends to watch in biotech in 2024

Wikipedia

It's time to get medical device identifiers over the finish line

It's time to get medical device identifiers over the finish line

Beach reads and more: STAT's 2023 summer book list

Grail spinoff by Illumina should end disastrous merger attempt

Racing yachts have close encounter with pod of orcas near Strait of Gibraltar

N.Y. state detects polio case, first in the U.S. since 2013

hotspot

focus

explore

entertainment